Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Immune Directed Individualized Elimination Therapy (iDIET) Study

NCT: NCT05543512 · COMPLETED

NCT IDNCT05543512
StatusCOMPLETED
Start Date2022-10-14
Completion2025-12-18

Brief Summary

This is a randomized, double blind, sham-controlled, pilot/feasibility trial of individualized dietary elimination treatment.

Frequently Asked Questions

What is The Immune Directed Individualized Elimination Therapy (iDIET) Study?

The Immune Directed Individualized Elimination Therapy (iDIET) Study is a clinical trial registered under NCT05543512. Current status: COMPLETED.

What is the status of NCT05543512?

The current status of NCT05543512 (The Immune Directed Individualized Elimination Therapy (iDIET) Study) is: COMPLETED.

When did The Immune Directed Individualized Elimination Therapy (iDIET) Study start?

The Immune Directed Individualized Elimination Therapy (iDIET) Study started on 2022-10-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑